Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Selinexor in Advanced Liposarcoma

Sarcoma

This is a randomized, multicenter, double-blind, placebo-controlled, Phase 2-3 study of patients diagnosed with advanced unresectable dedifferentiated liposarcoma. Approximately 279 total patients will be randomized to study treatment (selinexor or placebo).
Sarcoma
II/III
Davis, Elizabeth
NCT02606461
VICCSAR1879

Daunorubicin and Cytarabine with or without Uproleselan in Treating Older Adult Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

This phase II / III trial studies how well daunorubicin and cytarabine with or without uproleselan works in treating older adult patients with acute myeloid leukemia receiving intensive induction chemotherapy. Drugs used in chemotherapy, such as daunorubicin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Uproleselan may prevent cancer from returning or getting worse. Giving daunorubicin and cytarabine with uproleselan may work better in treating patients with acute myeloid leukemia compared to daunorubicin and cytarabine alone.
Not Available
II/III
Strickland, Stephen
NCT03701308
ECOGHEMA041701

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: